Your search for hemodialysis returned 1966 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for hemodialysis returned 1966 results

Sort Results:

Relevant Recent

Meeting Size Doesn’t Matter

Renal & Urology News provides news coverage of about two dozen national and international meetings annually. Some of these meetings are a lot smaller than the annual meetings of the American Society of Nephrology and American Urological Society, but that does not mean we take them less seriously from a news standpoint.

BMI Not Linked to Death In Stage 3-4 CKD

Higher BMI is associated with worse survival in the general population, but appears to confer a survival advantage in patients on hemodialysis.

Pre-ESRD Care Cuts Early Mortality

Patients with end-stage renal disease (ESRD) are at higher risk of death within the first 120 days of hemodialysis compared with 121-365 days after hemodialysis initiation, according to a report.

Lower Pulse Pressure Hikes Mortality

Reduced mean arterial pressure (MAP) and pulse pressure (PP) are associated with increased mortality in hemodialysis patients, according to a study.

Lanthanum Not More Harmful

The phosphate binder lanthanum carbonate does not adversely affect cognitive function in hemodialysis patients compared with standard phosphate binders, according to a study published in Kidney International (2007;71:252-259).

Growth Hormone May Help Dialysis Patients

Growth hormone therapy may safely improve lean body mass (LBM), cardiovascular risk factors, and quality of life in adult patients on maintenance hemodialysis, data suggest.
World Literature Review

Valve Calcifications Linked to Mineral Abnormalities

Data from a Moroccan study implicate calcium and phosphate metabolism abnormalities in the pathogenesis of heart valve calcifications in patients on hemodialysis.

Vitamin E-Coated Filters Fight Anemia

Long-term use of vitamin E-coated polysulfone membrane (VECM) dialysis filters may significantly improve hemoglobin levels and reduce requirements of erythropoietin (EPO), according to an Italian study.

No Marker IDs Nonresponders to IV Iron

SAN DIEGO—No baseline transferrin saturation (TSAT), serum ferritin, or soluble transferrin receptor value predicts how hemodialysis patients with high ferritin levels will respond to IV iron therapy.
Next post in News